Supplementary Table 1 from Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer

MLA

Samuel C. Mok, et al. Supplementary Table 1 from Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22450074.v1.

APA

Samuel C. Mok, Michael J. Birrer, Kwong-Kwok Wong, Anil K. Sood, Gabriel Lopez-Berestein, Cristian Rodriguez-Aguay, Suet-Ying Kwan, Rosie S. Schmandt, Ngai-Na Co, Tom Harding, Cecilia S. Leung, Melissa S. Thompson, Tsz-Lun Yeung, & Tarrik M. Zaid. (2023). Supplementary Table 1 from Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer. https://doi.org/10.1158/1078-0432.22450074.v1

Chicago

Samuel C. Mok, Michael J. Birrer, Kwong-Kwok Wong, Anil K. Sood, Gabriel Lopez-Berestein, Cristian Rodriguez-Aguay, Suet-Ying Kwan, et al. 2023. “Supplementary Table 1 from Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer,” March. doi:10.1158/1078-0432.22450074.v1.